The recommendations released through the Cell-Cultivated Products Sandbox Programme mark the second installment of publications from the initiative funded by the Department of Science and Technology (DSIT), which is set to continue until February 2027.
The Food Standards Agency (FSA) indicated that these guidelines aim to equip businesses with the regulatory transparency necessary for confidently investing in and developing cutting-edge food products, while prioritizing consumer safety as the fundamental element in any market approach.
Key aspects of the guidance provided include:
Dr. Thomas Vincent, deputy director of innovation at the FSA, shared, “Cell-cultivated products represent a genuinely new frontier for the food industry, and we want businesses to have the clearest possible picture of what is required to bring safe products to market.”
He added, “This guidance reflects the knowledge we have built through engagement with industry and academia through the Sandbox and is designed to make the path to authorization more transparent and efficient. Consumer safety is non-negotiable, and these documents are ultimately about reducing barriers for emerging food technologies without compromising on safety standards.”
Professor Susan Jebb, chair of the FSA, commented: “Developments in the innovative food sector can support a healthier and more resilient food system while also contributing to the UK Government’s ambitions for a growing, modern economy. But that potential can only be realized if businesses have the regulatory clarity to invest and the confidence to scale up. This guidance provides practical support that helps innovative companies move forward, backed by a science-led approach that protects public health.”
